No Data
Genmab Upgraded to Outperform at William Blair
Trump Set To Meet Top Executives From Apple, JPMorgan And Other Giants In Business Roundtable Amid Economic Concerns And Market Downturn: Report
Verizon CRO Issues Warning on Competitive Landscape, Softening Demand
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday
The Analyst Verdict: Gilead Sciences In The Eyes Of 14 Experts
Xilio Therapeutics Q4 2024 GAAP EPS $(0.20) Beats $(0.21) Estimate, Xilio Anticipates That Its Cash And Cash Equivalents Of $55.3M As Of December 31, 2024, Together With The $52M Upfront Payments Received From AbbVie Is Expected To Provide Cash Runway...